NCT06340789View on ClinicalTrials.gov

Neurotransmitters in Treatment Resistant Schizophrenia Patients With add-on Sodium Benzoate

PHASE2Not yet recruitingINTERVENTIONAL
Enrollment

90

Participants

Timeline

Start Date

April 10, 2024

Primary Completion Date

April 30, 2025

Study Completion Date

April 30, 2025

Conditions
Symptom, CognitiveSchizophreniaSchizo Affective Disorder
Interventions
DRUG

Sodium Benzoate 2gram/day

the add-on sodium benzoate with conventional pharmacological treatment

DRUG

Placebo

the add-on placebo with conventional pharmacological treatment

All Listed Sponsors
lead

National Cheng-Kung University Hospital

OTHER